A large international study led by scientists at FIMM, University of Helsinki, shows that many of the molecular differences ...

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.

At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...

G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...